These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16431395)

  • 21. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA; El-Bagory I; Bayomi MA
    Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of dissolution medium on the release of diltiazem hydrochloride from carbomeric matrices].
    Sedláková M; Rabisková M; Svajdlenka E
    Ceska Slov Farm; 2006 Mar; 55(2):65-71. PubMed ID: 16570583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium.
    Kakish HF; Tashtoush B; Ibrahim HG; Najib NM
    Eur J Pharm Biopharm; 2002 Jul; 54(1):75-81. PubMed ID: 12084505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and in vivo evaluation of diclofenac sodium sustained release matrix tablet: effect of compression force.
    Taha EI; Shazly GA; Harisa GI; Barakat NS; Al-Enazi FK; Elbagory IM
    Pak J Pharm Sci; 2015 Mar; 28(2):573-9. PubMed ID: 25730790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets.
    Muschert S; Siepmann F; Leclercq B; Carlin B; Siepmann J
    Eur J Pharm Biopharm; 2009 May; 72(1):130-7. PubMed ID: 19146955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
    Lamoudi L; Chaumeil JC; Daoud K
    Drug Dev Ind Pharm; 2012 May; 38(5):515-20. PubMed ID: 21978389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of controlled release matrix tablets of diclofenac sodium, ciprofloxacin hydrochloride, and theophylline.
    Saha RN; Sajeev C; Sahoo J
    Drug Deliv; 2001; 8(3):149-54. PubMed ID: 11570595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
    Al-Taani BM; Tashtoush BM
    AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.